報價延遲最少15分鐘:2025/05/24 21:52 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
8.4 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
8.40/-0.04
|
|
企業價值
8.81M
|
| 資產負債 |
|
每股賬面淨值
10.84
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
404.10K
|
|
每股收益
2.22
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/24 21:52 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products. |